Understanding the Complaints About Restasis
•
4 min read
Restasis (cyclosporine ophthalmic emulsion) was the first FDA-approved medication to treat chronic dry eye disease, but its use comes with several commonly cited drawbacks and **complaints about Restasis**. While effective for many in increasing the eyes' natural tear production, patient reviews frequently mention an initial stinging sensation, frustration with the slow onset of therapeutic effects, high costs, and challenges with the multi-dose bottle design.
